Demcizumab
M18-004
Phase 1 small_molecule completed
Quick answer
Demcizumab for Non Small Cell Lung Cancer is a Phase 1 program (small_molecule) at Mereo BioPharma Group plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mereo BioPharma Group plc
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed